InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Meyer Andrew Hollman. Director active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 11 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €22k. History available since 27 September 2024. The latest transaction was disclosed on 2 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Meyer Andrew Hollman is a declarant linked to Janux Therapeutics, Inc. (XNAS), where he serves as Chief Business Officer. He has 7 filings in total, and the sampled recent filings run from 2024-09-27 to 2025-05-02, with the transaction nature listed as option exercise and buy and sell amounts of EUR 0 each.